Graffiti
K-Number: K202189 · 2020-12-08
Decision Date2020-12-08
Product CodeDQK
Advisory CommitteeCV
DecisionSubstantially Equivalent
Device Summary
Graffiti is a medical device manufactured by Ge Medical Systems Information Technologies, Inc.. It received FDA 510(k) clearance on 2020-12-08 under approval number K202189. The device is classified under product code DQK. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.
Frequently Asked Questions
What is the Graffiti?
Graffiti is a medical device that received FDA 510(k) clearance on 2020-12-08. It is manufactured by Ge Medical Systems Information Technologies, Inc.. The 510(k) number is K202189.
When was Graffiti approved by the FDA?
Graffiti received FDA 510(k) clearance on 2020-12-08, under approval number K202189.
What company makes Graffiti?
Graffiti is manufactured by Ge Medical Systems Information Technologies, Inc..
What is the FDA product code for Graffiti?
The FDA product code for Graffiti is DQK.
Other Devices by Ge Medical Systems Information Technologies, Inc.
Related Devices (Code: DQK)
K160218AutoMark ModuleSt Jude Medical
K160210EnSite Precision Cardiac Mapping System v2.0St Jude Medical
K162643MediGuide Technology SystemSt Jude Medical
K162440CardioInsight Cardiac Mapping SystemCardioinsight Technologies, Inc.
K160187Ensite Velocity Cardiac Mapping System v5.0, Ensite Automap Module v1.0St Jude Medical
K160186EnSite Velocity Surface Electrode KitSt Jude Medical
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.